AVBP
Price
$21.97
Change
-$0.32 (-1.44%)
Updated
Dec 26 closing price
Capitalization
906.95M
89 days until earnings call
Intraday BUY SELL Signals
BBIO
Price
$75.80
Change
-$0.73 (-0.95%)
Updated
Dec 26 closing price
Capitalization
14.61B
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVBP vs BBIO

Header iconAVBP vs BBIO Comparison
Open Charts AVBP vs BBIOBanner chart's image
ArriVent BioPharma
Price$21.97
Change-$0.32 (-1.44%)
Volume$215.32K
Capitalization906.95M
BridgeBio Pharma
Price$75.80
Change-$0.73 (-0.95%)
Volume$1.09M
Capitalization14.61B
AVBP vs BBIO Comparison Chart in %
View a ticker or compare two or three
VS
AVBP vs. BBIO commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVBP is a Buy and BBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (AVBP: $21.97 vs. BBIO: $75.80)
Brand notoriety: AVBP and BBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVBP: 56% vs. BBIO: 46%
Market capitalization -- AVBP: $906.95M vs. BBIO: $14.61B
AVBP [@Biotechnology] is valued at $906.95M. BBIO’s [@Biotechnology] market capitalization is $14.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVBP’s FA Score shows that 1 FA rating(s) are green whileBBIO’s FA Score has 1 green FA rating(s).

  • AVBP’s FA Score: 1 green, 4 red.
  • BBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVBP and BBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVBP’s TA Score shows that 3 TA indicator(s) are bullish while BBIO’s TA Score has 3 bullish TA indicator(s).

  • AVBP’s TA Score: 3 bullish, 5 bearish.
  • BBIO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than AVBP.

Price Growth

AVBP (@Biotechnology) experienced а -0.18% price change this week, while BBIO (@Biotechnology) price change was -0.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

AVBP is expected to report earnings on Mar 26, 2026.

BBIO is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($14.6B) has a higher market cap than AVBP($907M). BBIO YTD gains are higher at: 176.239 vs. AVBP (-17.530). AVBP has higher annual earnings (EBITDA): -162.42M vs. BBIO (-640.87M). BBIO has more cash in the bank: 646M vs. AVBP (300M). AVBP has less debt than BBIO: AVBP (56K) vs BBIO (1.86B). BBIO has higher revenues than AVBP: BBIO (354M) vs AVBP (0).
AVBPBBIOAVBP / BBIO
Capitalization907M14.6B6%
EBITDA-162.42M-640.87M25%
Gain YTD-17.530176.239-10%
P/E RatioN/AN/A-
Revenue0354M-
Total Cash300M646M46%
Total Debt56K1.86B0%
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVBPBBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AVBP
Daily Signal:
Gain/Loss:
BBIO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFEIX42.210.04
+0.09%
JPMorgan Europe Dynamic L
ILGJX18.750.01
+0.05%
Columbia Integrated Large Cap Gr Ins 3
ACGCX38.80N/A
N/A
American Century Discplnd Cor Val C
BBTLX16.95-0.14
-0.82%
Bridge Builder Tax Managed Large Cap
GNXAX17.89-0.40
-2.19%
AlphaCentric Robotics and Automation A

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with DNLI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-1.44%
DNLI - AVBP
52%
Loosely correlated
-0.71%
CRNX - AVBP
51%
Loosely correlated
-1.54%
SYRE - AVBP
51%
Loosely correlated
-0.33%
RVMD - AVBP
50%
Loosely correlated
-0.54%
XNCR - AVBP
50%
Loosely correlated
-1.49%
More

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with AXON. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-0.95%
AXON - BBIO
44%
Loosely correlated
-1.24%
ARRY - BBIO
43%
Loosely correlated
+0.39%
PMN - BBIO
43%
Loosely correlated
-7.38%
AVBP - BBIO
42%
Loosely correlated
-1.44%
XENE - BBIO
42%
Loosely correlated
-0.38%
More